Portfolio Update

Merrill Lynch Greater Europe IT PLC 16 April 2007 MERRILL LYNCH GREATER EUROPE INVESTMENT TRUST plc All information is at 31 March 2007 and unaudited. Performance at month end with net income reinvested One Three One Since launch Month Months Year (20Sep04) Net asset value 2.8% 3.5% 9.6% 82.9% Share price 2.5% 4.2% 10.2% 76.4% FTSE World Europe ex UK 3.7% 4.2% 12.4% 72.0% Sources: BlackRock and Datastream. At month end Net asset value: 178.55p Includes net revenue of 0.37p Share price: 172.00p Discount to NAV: 3.7% Gearing: 5.7% Net yield: 1.2% Total assets: £235.0m Ordinary shares in issue: 124,729,045 Benchmark Sector Analysis Total Assets Index Country Analysis Total Assets (%) (%) (%) Financials 36.3 33.6 Germany 20.2 Healthcare 12.3 6.7 France 15.4 Industrials 11.6 12.0 Switzerland 11.9 Oil & Gas 9.4 5.9 Italy 7.9 Basic Materials 8.9 5.7 Russia 7.9 Consumer Goods 4.6 13.1 Spain 7.6 Utilities 4.4 7.3 Ireland 4.9 Consumer Services 4.1 5.4 Netherlands 4.2 Telecommunications 4.1 6.1 Turkey 3.2 Other Investments 3.0 - Finland 2.5 Technology 1.8 4.2 Greece 2.3 Net current liabilities (0.5) - Israel 2.1 Belgium 1.9 Sweden 1.8 Denmark 1.7 Norway 1.6 Poland 1.1 UK 1.0 Cyprus 0.8 Austria 0.5 Net current liabilities (0.5) ----- ----- ----- 100.0 100.0 100.0 ----- ----- ----- Ten Largest Equity Investments Company Country of Risk Allianz Germany AXA France Banco Santander Spain BBVA Spain BlackRock Eurasian Frontiers Fund Russia Credit Suisse Switzerland Novartis Switzerland Roche Holdings Switzerland Societe Generale France Telefonica Spain Commenting on the markets, James Macmillan, representing the Investment Manager noted: European equities delivered above average returns in a global context during March and recovered almost all the losses incurred at the end of the February sell-off. The FTSE World Europe ex UK Index (net) returned 3.7%. Performance in Emerging Europe was also strong especially in the second half of the month and the MSCI Emerging Europe Index returned 5.5%. M&A activity continued to be a major driver of market performance with high profile activity across a range of sectors, and the oil price rose significantly in the last week of March on the back of geopolitical risk. The Company's NAV returned 2.8% during February, underperforming the reference index by 0.9%. The contribution from the Emerging Europe region was helpful with Poland and Turkey having a positive contribution to performance. The use of flexible gearing was beneficial in a rising market. During the month the Company benefited from stock selection in selected holdings in the utility, chemical, energy and steel sectors; individual stocks included power utility EDF, pharmaceutical group Bayer, Neste Oil, and Novolipetsk Steel. The main detractor to the Company's performance relative to its reference benchmark was not owning stocks which rose significantly on M&A activity and restructuring speculation. Such stocks included car manufacturers Daimler Chrysler and Volkswagen, bank ABN Amro and chemical group Akzo Nobel. Other stocks to have a negative contribution to performance were selected holdings in banking, insurance and construction. During the month the Company increased its exposure to the material and technology sectors through the purchase of holdings in chemical group Akzo Nobel and handset manufacturer Nokia. This was partially funded by reducing exposure to investment banks and pharmaceuticals through the sale of shares in UBS and Altana. The Company continues to have a bias towards financials, through banks and diversified financials, along with pharmaceuticals, materials and energy. Exposure to Emerging Europe increased during the month to finish at 14.3%, with key country exposures being Turkey, Russia and the BlackRock Eurasian Frontiers Hedge Fund. During the month the Company reduced its net market exposure to 105.7%. We remain positive on the prospects for European and emerging European equities. Despite recent market volatility the latest evidence appears to suggest that the Global economy remains in reasonable health with a slight tempering of growth rather than the emergence of a recession or a serious slowdown. Companies have generally reported good Q4 results, with decent earnings growth and record profits and this has been driven by a pick up in domestic consumer demand as well as robust global export demand. We believe a combination of cheaply available finance, strong earnings and attractive valuations should allow the market to make progress against what may be a more challenging international backdrop. Latest Latest information is available by typing www.blackrock.co.uk/its on the internet, 'BLRKINDEX' on Reuters, 'BLRK' on Bloomberg or '8800' on Topic 3 (ICV terminal). 16 April 2007 This information is provided by RNS The company news service from the London Stock Exchange PFUILFLRSTIRLID
UK 100

Latest directors dealings